Mark Schoenberg
Director Técnico/Científico/I+D en UROGEN PHARMA LTD. .
Fortuna: 2 M $ al 31/05/2024
Perfil
Mark P.
Schoenberg is currently the Chief Medical Officer at UroGen Pharma Ltd.
He is also a Member of The American Association of Cancer Research, the Society of Urologic Nurses & Associates, and the Society of Urologic Oncology, Inc. Previously, he worked as a Professor at The Johns Hopkins University from 2005 to 2014 and as the Chief Medical Officer at Sonablate Corp.
Dr. Schoenberg completed his undergraduate degree at Yale University and his doctorate at the University of Texas Health Center.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
UROGEN PHARMA LTD.
0.40% | 10/06/2024 | 144 284 ( 0.40% ) | 2 M $ | 31/05/2024 |
Cargos activos de Mark Schoenberg
| Empresas | Cargo | Inicio |
|---|---|---|
| UROGEN PHARMA LTD. | Director Técnico/Científico/I+D | 09/02/2016 |
| The American Association of Cancer Research | Corporate Officer/Principal | - |
| Society of Urologic Oncology, Inc. | Corporate Officer/Principal | - |
Society of Urologic Nurses & Associates
 Society of Urologic Nurses & Associates Miscellaneous Commercial ServicesCommercial Services Society of Urologic Nurses & Associates operates as a nonprofit organization. The firm supports urologic health care professionals. It specializes in advancing urologic nursing practice and patient care. The company was founded in 1972 and is headquartered in Pitman, NJ. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Mark Schoenberg.
| Empresas | Cargo | Fin |
|---|---|---|
| The Johns Hopkins University | Corporate Officer/Principal | 01/01/2014 |
Sonablate Corp.
 Sonablate Corp. Medical SpecialtiesHealth Technology Sonablate Corp. develops and manufactures high intensity focused ultrasound surgical ablation systems. Its products include Sonablate 450, a HIFU solution that determines the safety and efficacy of a minimally invasive prostate cancer treatment; Sonablate 500, a HIFU surgical ablation system for the treatment of localized prostate cancer that delivers ablative therapy with the possibility of reducing side effects; and Sonatherm, a laparoscopic HIFU surgical ablation system that uses a laparoscopic probe to deliver robotic ablative therapy to soft tissue with a customizable ablation zone. The company was founded by Stephen R. Puckett Sr. and George M. Suarez in 2004 and is headquartered in Charlotte, NC. | Director Técnico/Científico/I+D | - |
Formación de Mark Schoenberg.
| Yale University | Undergraduate Degree |
| University of Texas Health Center | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| UROGEN PHARMA LTD. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Society of Urologic Nurses & Associates
Society of Urologic Nurses & Associates Miscellaneous Commercial ServicesCommercial Services Society of Urologic Nurses & Associates operates as a nonprofit organization. The firm supports urologic health care professionals. It specializes in advancing urologic nursing practice and patient care. The company was founded in 1972 and is headquartered in Pitman, NJ. | Commercial Services |
Sonablate Corp.
Sonablate Corp. Medical SpecialtiesHealth Technology Sonablate Corp. develops and manufactures high intensity focused ultrasound surgical ablation systems. Its products include Sonablate 450, a HIFU solution that determines the safety and efficacy of a minimally invasive prostate cancer treatment; Sonablate 500, a HIFU surgical ablation system for the treatment of localized prostate cancer that delivers ablative therapy with the possibility of reducing side effects; and Sonatherm, a laparoscopic HIFU surgical ablation system that uses a laparoscopic probe to deliver robotic ablative therapy to soft tissue with a customizable ablation zone. The company was founded by Stephen R. Puckett Sr. and George M. Suarez in 2004 and is headquartered in Charlotte, NC. | Health Technology |
| The American Association of Cancer Research | |
| Society of Urologic Oncology, Inc. |
- Bolsa de valores
- Insiders
- Mark Schoenberg
